Cargando…
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
Management of clinically aggressive meningiomas is a considerable challenge. PD-L1 induced immune suppression has increasingly gained attention in clinical management of cancer; however, to date, the clinical significance and regulatory mechanisms of PD-L1 in meningioma is not yet fully characterize...
Autores principales: | Karimi, Shirin, Mansouri, Sheila, Mamatjan, Yasin, Liu, Jeff, Nassiri, Farshad, Suppiah, Suganth, Singh, Olivia, Aldape, Kenneth, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445252/ https://www.ncbi.nlm.nih.gov/pubmed/32839486 http://dx.doi.org/10.1038/s41598-020-70514-z |
Ejemplares similares
-
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019) -
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
por: Karimi, Shirin, et al.
Publicado: (2021) -
Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of ODZ1 Gene Expression
por: Velásquez, Carlos, et al.
Publicado: (2019) -
Special issue: a contemporary landscape of the clinical and biological research in neurofibromatosis type 1
por: Suppiah, Suganth, et al.
Publicado: (2020) -
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
por: Agnihotri, Sameer, et al.
Publicado: (2017)